These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9295125)

  • 1. Cytokine gene therapy of cancer using gene gun technology: superior antitumor activity of interleukin-12.
    Rakhmilevich AL; Janssen K; Turner J; Culp J; Yang NS
    Hum Gene Ther; 1997 Jul; 8(11):1303-11. PubMed ID: 9295125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A convenient cancer vaccine therapy with in vivo transfer of interleukin 12 expression plasmid using gene gun technology after priming with irradiated carcinoma cells.
    Nishitani MA; Sakai T; Ishii K; Zhang M; Nakano Y; Nitta Y; Miyazaki J; Kanayama HO; Kagawa S; Himeno K
    Cancer Gene Ther; 2002 Feb; 9(2):156-63. PubMed ID: 11857033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene gun-mediated IL-12 gene therapy induces antitumor effects in the absence of toxicity: a direct comparison with systemic IL-12 protein therapy.
    Rakhmilevich AL; Timmins JG; Janssen K; Pohlmann EL; Sheehy MJ; Yang NS
    J Immunother; 1999 Mar; 22(2):135-44. PubMed ID: 10093038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen beta-galactosidase and the BALB/c Meth A p53 tumor-specific antigen.
    Tüting T; Gambotto A; Robbins PD; Storkus WJ; DeLeo AB
    Gene Ther; 1999 Apr; 6(4):629-36. PubMed ID: 10476222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of specific CD8+ T cells in the tumor and blood is associated with efficient local IL-12 gene therapy of cancer.
    Fernandez NC; Levraud JP; Haddada H; Perricaudet M; Kourilsky P
    J Immunol; 1999 Jan; 162(1):609-17. PubMed ID: 9886439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism.
    Rakhmilevich AL; Janssen K; Hao Z; Sondel PM; Yang NS
    Cancer Gene Ther; 2000 Jun; 7(6):826-38. PubMed ID: 10880012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined GM-CSF and IL-12 gene therapy synergistically suppresses the growth of orthotopic liver tumors.
    Chang CJ; Chen YH; Huang KW; Cheng HW; Chan SF; Tai KF; Hwang LH
    Hepatology; 2007 Mar; 45(3):746-54. PubMed ID: 17326190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined IL-12 and GM-CSF gene therapy for murine hepatocellular carcinoma.
    Wang Z; Qiu SJ; Ye SL; Tang ZY; Xiao X
    Cancer Gene Ther; 2001 Oct; 8(10):751-8. PubMed ID: 11687898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of interleukin 12 and interferon alpha gene therapy induces a synergistic antitumor response against colon and renal cell carcinoma.
    Mendiratta SK; Quezada A; Matar M; Thull NM; Bishop JS; Nordstrom JL; Pericle F
    Hum Gene Ther; 2000 Sep; 11(13):1851-62. PubMed ID: 10986558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation of antitumor immunity by tumor cells transduced with a retroviral vector carrying the interleukin-2 and interferon-gamma cDNAs.
    Rosenthal FM; Cronin K; Bannerji R; Golde DW; Gansbacher B
    Blood; 1994 Mar; 83(5):1289-98. PubMed ID: 8118032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral delivery of dendritic cells engineered to secrete both interleukin (IL)-12 and IL-18 effectively treats local and distant disease in association with broadly reactive Tc1-type immunity.
    Tatsumi T; Huang J; Gooding WE; Gambotto A; Robbins PD; Vujanovic NL; Alber SM; Watkins SC; Okada H; Storkus WJ
    Cancer Res; 2003 Oct; 63(19):6378-86. PubMed ID: 14559827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 12 gene transfer into skin distant from the tumor site elicits antimetastatic effects equivalent to local gene transfer.
    Oshikawa K; Rakhmilevich AL; Shi F; Sondel PM; Yang N; Mahvi DM
    Hum Gene Ther; 2001 Jan; 12(2):149-60. PubMed ID: 11177552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic inhibition of tumor growth in a murine mammary adenocarcinoma model by combinational gene therapy using IL-12, pro-IL-18, and IL-1beta converting enzyme cDNA.
    Oshikawa K; Shi F; Rakhmilevich AL; Sondel PM; Mahvi DM; Yang NS
    Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13351-6. PubMed ID: 10557324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-lasting gene expression by particle-mediated intramuscular transfection modified with bupivacaine: combinatorial gene therapy with IL-12 and IL-18 cDNA against rat sarcoma at a distant site.
    Ajiki T; Murakami T; Kobayashi Y; Hakamata Y; Wang J; Inoue S; Ohtsuki M; Nakagawa H; Kariya Y; Hoshino Y; Kobayashi E
    Cancer Gene Ther; 2003 Apr; 10(4):318-29. PubMed ID: 12679805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity.
    Hwang KS; Cho WK; Yoo J; Seong YR; Kim BK; Kim S; Im DS
    Cancer Gene Ther; 2004 Jun; 11(6):397-407. PubMed ID: 15044962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene gun application in the generation of effector T cells for adoptive immunotherapy.
    Tanigawa K; Yu H; Sun R; Nickoloff BJ; Chang AE
    Cancer Immunol Immunother; 2000 Feb; 48(11):635-43. PubMed ID: 10663611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus-mediated interleukin-12 gene transfer combined with cytosine deaminase followed by 5-fluorocytosine treatment exerts potent antitumor activity in Renca tumor-bearing mice.
    Hwang KS; Cho WK; Yoo J; Yun HJ; Kim S; Im DS
    BMC Cancer; 2005 May; 5():51. PubMed ID: 15910693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage-derived chemokine gene transfer results in tumor regression in murine lung carcinoma model through efficient induction of antitumor immunity.
    Guo J; Wang B; Zhang M; Chen T; Yu Y; Regulier E; Homann HE; Qin Z; Ju DW; Cao X
    Gene Ther; 2002 Jun; 9(12):793-803. PubMed ID: 12040461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.